| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 424523000 | Fish oil or solidified form thereof | 62 |
| 20080254135 | RESVERATROL-CONTAINING COMPOSITIONS FOR GENERAL HEALTH AND VITALITY - The present invention is directed towards an orally administered composition comprising multiple plant extracts, which are characterized as having high ORAC values, and promote an increase in a mammal's dietary intake of antioxidant and polyphenols to a therapeutically effective amount. The ingredients of the present compositions represent a broad spectrum of polyphenols providing antioxidant activity for the purpose of improving general health and vitality by enhancing cardioprotection and immune system functions. The composition of the present invention comprises an extract of | 10-16-2008 |
| 20090110745 | Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging - The present invention provides methods for improving cognitive function, improving mood, and decreasing aggression in a normal adult subject, and in a subject having symptoms characteristic of a neurological disorder, by administration of a nutriceutical formulation of the invention to the subject. The invention additionally features methods of treating neurological disorders, depression, and aggression using nutriceutical formulations. Nutriceutical compositions and formulations for use in the methods of the invention, and kits containing nutriceutical compositions and formulations, are also provided. | 04-30-2009 |
| 20090117197 | COMPOSITIONS AND METHODS FOR AMELIORATING CACHEXIA - The invention provides preparations, formulations, kits and other products of manufacture (e.g., blister packs) comprising combinations of beneficial ingredients that are serviceable as therapies for improving states and disease symptoms such as involving inflammation, excessive sympathoneural drive, cachexia, anorexia, and anorexia-cachexia, as well as stress or anxiety related thereto, and methods of making and using them. The invention provides compositions and therapies comprising use of a beta adrenergic antagonist (also called “beta blockers”, e.g., propranolol) in combination with an anti-inflammatory agent, e.g., a nonsteroidal anti-inflammatory drug (NSAID), an angiotensin-converting enzyme (ACE) inhibitor, an angiotensin receptor blocker (ARB), an anabolic steroid, a natural oil or fatty acid or any combination thereof. | 05-07-2009 |
| 20090130219 | Composition for Improving Lipid Metabolism - Disclosed is a composition for improving lipid metabolism. | 05-21-2009 |
| 20090186096 | Applications of microencapsulated essential oils - A new method for the preparation of microencapsulated essential oils is disclosed. The microcapsules containing essential oils or a formulation containing thereof may be used for various non-agricultural applications. | 07-23-2009 |
| 20090246289 | SYSTEM AND METHOD FOR DIAGNOSING AND MANAGING THOSE AT RISK FOR CARDIOVASCULAR DISEASE - A system and method for diagnosing and managing patients at risk for cardiovascular disease. The system and method provides for automating the ordering of a number of advanced tests, compiling and evaluating test results, and producing an automated report which includes recommended disease management options. | 10-01-2009 |
| 20090258081 | NEW PLANT DERIVED SEED EXTRACT RICH IN ESSENTIALLY FATTY ACIDS DERIVED FROM SALVIA HISPANICA L. SEED: COMPOSITION OF MATTER, MANUFACTURING PROCESS AND USE | 10-15-2009 |
| 20100068292 | Novel Inhibitors of Arachidonic Acid Formation - The invention relates to a novel class of inhibitors of arachidonic acid formation that can be useful for treating inflammatory conditions. Specifically, the invention relates to derivatives of sesamol that confer lower toxicity and increased circulatory lifetimes than pure sesamol. | 03-18-2010 |
| 20100074963 | Red Palm Oil and Fish Oil Wound Dressing - A cosmeceutically acceptable formulation as a wound dressing including red palm oil and a triglyceride, preferably fish oil, preferably derived from salmon. Another aspect of this disclosure is providing a mixture of red palm oil and very long chain (>C | 03-25-2010 |
| 20100104657 | PHARMACEUTICAL COMPOSITION COMPRISING A REDUCED CONCENTRATION OF CHOLESTEROL - The invention relates to a process for decreasing the amount of cholesterol in a mixture comprising a marine oil, the marine oil containing the cholesterol, which process comprises the steps of adding a volatile working fluid to the mixture, where the volatile working fluid comprises at least one of a fatty acid ester, a fatty acid amide and a hydrocarbon, and subjecting the mixture with the added volatile working fluid to at least one stripping processing step, in which an amount of cholesterol present in the marine oil in free form is separated from the mixture together with the volatile working fluid. The present invention also relates to a volatile cholesterol decreasing working fluid and a health supplement and a pharmaceutical, based on a marine oil, prepared according to the process mentioned above. | 04-29-2010 |
| 20100183734 | Influence of genotype on susceptibility to treatment with fish oil - The present invention relates to methods for assessing an individual's susceptibility to treatment of an inflammatory disease with a dietary supplement. The invention describes the recognition that the sensitivity of an individual to the inflammation suppressing effects of fish oil on TNF-a production is linked both to genetic variation encoded by, or associated with, TNF-a and/or IL-6 single nucleotide polymorphisms and to the inherent level of production of TNF-a by cells. | 07-22-2010 |
| 20100196496 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF - There are provided various compounds and compositions comprising polyunsaturated fatty acid monoglycerides and derivatives thereof. These compounds and compositions can be useful as cancer chemopreventive agents. They can also be useful for enhancing solubility of various active agents and enhancing their bioavailability. | 08-05-2010 |
| 20100215761 | COMPOSITION FOR REGULATING LIPID METABOLISM - This invention concerns a composition for regulating lipid metabolism and methods that may be used in the food industry as well as in the nutraceutical and therapeutic fields. In particular, the invention involves food additives or supplements, a composition containing these and the use thereof, in particular for revitalizing a subject's metabolism, in particular, that of human beings. | 08-26-2010 |
| 20100233280 | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions - A composition is provided which includes an enriched fish oil as a lipid source. Also provided is a composition which includes a fatty acid of a fish oil and a medium-chain triglyceride, wherein the composition is an oil-in-water emulsion. | 09-16-2010 |
| 20100233281 | PROCESS FOR DECREASING ENVIRONMENTAL POLLUTANTS IN AN OIL OR A FAT. - The invention relates to a process for decreasing the amount of environmental pollutants in a mixture comprising a fat or an oil, being edible or for use in cosmetics, the fat or oil containing the environmental pollutants, which process comprises the steps of adding a volatile working fluid to the mixture, where the volatile working fluid comprises at least one of a fatty acid ester, a fatty acid amide, a free fatty acid and a hydro-carbon, and subjecting the mixture with the added volatile working fluid to at least one stripping processing step, in which an amount of environmental pollutant present in the fat or oil, being edible or for use in cosmetics, is separated from the mixture together with the volatile working fluid. The present invention also relates to a volatile environmental pollutants decreasing working fluid, for use in decreasing an amount of environmental pollutants present in a fat or oil, being edible or for use in cosmetics. In addition, the present invention relates to a health supplement, a pharmaceutical and an animal feed product prepared according to the process mentioned above. | 09-16-2010 |
| 20100272824 | COMPOSITIONS AND METHODS FOR PREVENTING AND MONITORING DISEASE - Gene expression patterns were analyzed that identified multiple genes associated with radiation enhanced colon carcinogenesis. Some of the genes modulated by radiation exposure may be involved in up-regulating the Wnt/β-catenin signaling pathway and promote colon carcinogenesis. Consumption of a fish oil/pectin diet caused a general down-regulation of genes encoding proteins involved in cell adhesion and receptor activity, which may be involved in down-regulating the Wnt/β-catenin signaling pathway. The data suggest that dietary fish oil/pectin may be an effective countermeasure against radiation-induced colon carcinogenesis. In accordance with this, gene expression profiles can be monitored to reduce the risk of radiation induced carcinogenesis in high risk personnel (i.e., for example, astronauts) before, during, and/or after radiation exposure (i.e., for example, spaceflight), and/or to detect radiation-induced carcinogenesis so that an appropriate countermeasure administration can be implemented. The techniques are also targeted at non-invasively monitoring cancer patients after the primary cancer has been resected to determine if/when a secondary tumor develops. | 10-28-2010 |
| 20100291226 | Pharmaceutical Formulations Based on Apolar and Polar Lipids for Ophthalmic Use - The present invention refers to pharmaceutical formulations based on lipids for ophthalmic use comprising a phospholipid component composed of zwitterionic phospholipids of natural origin and an oily component composed of oils of natural origin emulsified in water. In particular, the invention refers to ophthalmic formulations useful, for example, for transporting drugs to the eye and in the treatment of ocular dryness, capable of restoring the lipid layer of the tear film. In particular, in a non-transitory but pathological situation such as the dry eye syndrome, such formulations also succeed in reducing the often-present inflammatory component. | 11-18-2010 |
| 20100323028 | METHOD AND COMPOSITION FOR TREATING PULMONARY HEMORRHAGE - The invention relates to methods and compositions for treating and preventing pulmonary hemorrhage in an animal, and for reducing red blood cells in the airways of an animal. More particularly, the invention relates to methods and compositions for treating and preventing pulmonary hemorrhage in an animal, and for reducing red blood cells in the airways of an animal wherein a feed composition comprising an about 3:1 to an about 1:3 ratio of docosahexaneoic acid to eicosapentaenoic acid is fed to the animal. | 12-23-2010 |
| 20110008457 | COMPOSITIONS AND METHODS FOR MODULATING LIPID COMPOSITION - The present subject matter relates to a novel herbal and oil composition and methods for modulating fatty acid composition and metabolism in an animal. In one aspect, the subject matter involves a composition comprising rosemary extract, oregano extract, and a polyunsaturated oil. In a particular embodiment, the polyunsaturated oil is fish oil or a derivative thereof. In some embodiments, the present subject matter relates to methods for modulating essential dietary fatty acid composition of lipoprotein particles or cell membranes, modulating essential fatty acid metabolism, regulating the activity of lipoxygenases and cyclooxygenases, improving cardiovascular health, and/or inhibiting cell proliferation diseases and disorders. | 01-13-2011 |
| 20110038943 | MILKWEED SEED OIL ADMINISTERED TO ANIMALS - Milkweed seed oil administered to an animal improves the health of the animal. This improvement is evidenced by the positive change in the analytical results of blood tests for cholesterol after the animal has been administered an effective amount of milkweed seed oil as compared to the blood test results of the animal before the milkweed seed oil was administered. | 02-17-2011 |
| 20110129542 | SUBSTITUTED AZEPINE- AND DIAZEPINE-SULFONAMIDES USEFUL TO INHIBIT 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1 - In its many embodiments, the present invention relates to a novel class of substituted azepine- and diazepine-sulfonamide compounds useful to inhibit 11β-hydroxysteroid dehydrogenase type-I, pharmaceutical compositions containing the compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the expression of 11β-hydroxysteroid dehydrogenase type-I using such compounds or pharmaceutical compositions. | 06-02-2011 |
| 20110212183 | ANTIOXIDANT COMPOSITION FOR MARINE OILS COMPRISING TOCOPHEROL, ROSEMARY EXTRACT, ASCORBIC ACID AND GREEN TEA EXTRACT - The present invention relates to compositions suitable for improving oxidative stability of marine oils, marine oils having improved oxidative stability as well as methods for manufacturing such compositions. | 09-01-2011 |
| 20110244052 | POLYUNSATURATED FATTY ACIDS FOR IMPROVING VISION - The invention provides an oral nutraceutical or pharmaceutical composition comprising at least one polyunsaturated fatty acid (PUFA) or a derivative thereof for use in treating defects of vision, e.g. long-sightedness (hyperopia). In some embodiments, the PUFA in the composition is provided by an oil purified from squid. | 10-06-2011 |
| 20110262550 | METHOD FOR TREATING A SKIN AILMENT - A method for treating a skin ailment by applying a personal composition from a collapsible dispenser. The collapsible dispenser includes a collapsible bag at least partially surrounded by an elastically deformable member and, optionally, an outer container body. Potential energy is generated by stretching the elastically deformable member, which is used to dispense the composition in lieu of a propellant or pump. The personal care composition may be a skin care composition, an antifungal, or an enzyme inhibiting composition. | 10-27-2011 |
| 20110268811 | COMPOSITION AND METHOD TO IMPROVE BLOOD LIPID PROFILES AND OPTIONALLY REDUCE LOW DENSITY LIPOPROTEIN (LDL) PER-OXIDATION IN HUMANS - A composition and method which improves blood lipid profiles and optionally reduces low density lipoprotein (LDL) per-oxidation in humans by administering a therapeutic amount of a composition comprising krill oil in combination with astaxanthin or a mixture of fish oil derived, choline based, phospholipid bound omega-3 fatty acid mixture including phospholipid bound polyunsaturated EPA and DHA. In one embodiment, the krill oil is derived from Euphasia spp., comprising Eicosapentaenoic (EPA) and Docosahexaenoic (DHA) fatty acids in the form of triacylglycerides and phospholipids. The krill oil includes at least 10% EPA and 5% DHA, of which greater than 50% are in the form of phospholipids and the 1-4000 mg of krill oil per daily dose is delivered. | 11-03-2011 |
| 20110293734 | NEW PLANT DERIVED SEED EXTRACT RICH IN ESSENTIALLY FATTY ACIDS DERIVED FROM SALVIA HISPANICA L. SEED: COMPOSITION OF MATTER, MANUFACTURING PROCESS AND USE | 12-01-2011 |
| 20110300227 | MALIGNANT NEOPLASM TREATMENT PROTOCOL - Methods, compositions, and strategies for the treatment of malignant neoplasms are presented herein. The treatment modalities are directed towards exploiting characteristics of cancer cells as well as correcting defective biochemical pathways and systems in the body. | 12-08-2011 |
| 20110300228 | COMPOSITION, WITH/WITHOUT AT LEAST ONE EASILY OXIDISED COMPONENT, COMPRISING AN EDIBLE PROCESSED OIL OR FAT MIXTURE, FOR PROMOTING GROWTH IN AN ANIMAL, PREVENTING OXIDATIVE STRESS, AVOIDING THAT FISH DEVELOP ENLARGED LIVER AND FEED COMPOSITION - The present invention relates to a composition for reducing the tendency of an animal to enter sexual maturation, reducing or preventing oxidative damage in an animal, for reducing or preventing oxidative stress in an animal, promoting growth of an animal and for avoiding enlarged liver size in fish. The present invention also relates to a composition having improved characteristics with regard to the stability of easily oxidised components during production and storage; and with regard to the utilization of the easily oxidised components. | 12-08-2011 |
| 20120251624 | NOVEL INHIBITORS OF ARACHIDONIC ACID FORMATION - The invention relates to a novel class of inhibitors of arachidonic acid formation that can be useful for treating inflammatory conditions. Specifically, the invention relates to derivatives of sesamol that confer lower toxicity and increased circulatory lifetimes than pure sesamol. | 10-04-2012 |
| 20120276212 | COMPOSITION COMPRISING PLANT AND/OR FISH OILS AND NON-OXIDIZABLE FATTY ACID ENTITIES - The present invention concerns a composition prepared from a combination of plant oil and/or fish oil and a compound comprising non. β-oxidizable fatty acid analogues, and the use of said composition for the preparation of a pharmaceutical or nutritional composition for the prevention and/or treatment of insulin resistance, obesity, diabetes, fatty liver, hypercholesterolemia, dyslipidemia, atherosclerosis, coronary heart disease, thrombosis, stenosis, secondary stenosis, myocardial infarction, stroke, elevated blood pressure, endothelial dysfunction, procoagulant state, polycystic ovary syndrome, the metabolic syndrome, cancer, inflammatory disorders and proliferate skin disorders. The present invention also concerns an animal feed prepared from a combination of plant oil and/or fish oil and a compound comprising non β-oxidizable fatty acid analogues, the use of said feed for improving the body composition of an animal, and a product produced from said animal. | 11-01-2012 |
| 20130004580 | DIVALENT CATION/TALC CONTAINING COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING ENZYMATIC IRRITATION - Compositions and methods for treating and/or preventing conditions such as diaper rash and atopic dermatitis are disclosed. The compositions and methods are particularly useful in the treatment and prevention of diaper rash and diaper dermatitis caused by the prolonged contact of human skin with body waste. The methods employ the topical application of a trypsin-inhibiting agent to the area in need of such treatment, or the area where prevention is desired. The trypsin-inhibiting agent is preferably a specified divalent cation, i.e., magnesium, in combination with talc. | 01-03-2013 |
| 20130052271 | Compositions and Methods for Treating Pain - The present invention provides compositions and methods for treating pain in mammals. A composition of the invention comprises one or more anti-inflammatory agents and optionally contains one or more anti-oxidants and immune system boosting agents. | 02-28-2013 |
| 20130156860 | METHOD FOR THE PREVENTION OF CHRONIC INFLAMMATION ASSOCIATED DISEASES - The present invention is related to a method for the prevention and possibly the treatment of chronic diseases, preferably inflammatory associated chronic diseases that may affect an animal including a human, by the administration of a sufficient amount of a (functional) food or feed to the diet of this animal. | 06-20-2013 |
| 20130216625 | TREATMENT OF INSULIN RESISTANCE OR DISEASES ASSOCIATED WITH INSULIN RESISTANCE - The present invention relates to the use of a substance with the core structure of formula (I), or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the manufacture of a composition for the treatment of insulin resistance or diseases associated with insulin resistance, preferably in human subject in a daily dosage in a range of from about 5 mg to about 1500 mg. The invention furthermore relates to a method of treating insulin resistance or diseases associated with insulin resistance in a mammal, said method comprises administering to said mamma, preferably a human subject, a substance with the core structure of formula (I), preferably in a daily dosage in a range from about 5 mg to about 1500 mg. The substance is preferably isosteviol or steviol, or pharmaceutically acceptable salts, solvates or prodrugs thereof. Examples of diseases associated with insulin resistance and e.g. type 2 diabetes mellitus, insulin resistance syndrome, impaired glucose tolerance, the metabolic syndrome, hyperglycemia, hyperinsulinemia, arterioselerosis, hypercholesterolemia, hypertriglyeridemia, hyperlipidemia, dyslipidemia, obesity, central obesity, polycystic ovarian syndrome, hypercoagulability, hypertension, microalbuminuria, or any combinations thereof. | 08-22-2013 |
| 20130266662 | VACCINIUM SPECIES COMPOSITIONS - This invention relates to novel compositions comprising as an active ingredient one or more berries, leaves, roots, and/or root barks obtained from one or more plant species of the genus | 10-10-2013 |
| 20130287858 | COMPOSITION AND METHOD TO IMPROVE BLOOD LIPID PROFILES AND OPTIONALLY REDUCE LOW DENSITY LIPOPROTEIN (LDL) PER-OXIDATION IN HUMANS - A composition and method which improves blood lipid profiles and optionally reduces low density lipoprotein (LDL) per-oxidation in humans by administering a therapeutic amount of a composition comprising krill oil in combination with astaxanthin or a mixture of fish oil derived, choline based, phospholipid bound omega-3 fatty acid mixture including phospholipid bound polyunsaturated EPA and DHA. In one embodiment, the krill oil is derived from | 10-31-2013 |
| 20130309316 | PLANT DERIVED SEED EXTRACT RICH IN ESSENTIAL FATTY ACIDS DERIVED FROM PERILLA SEED: COMPOSITION OF MATTER, MANUFACTURING PROCESS AND USE - A composition of matter comprises a shelf stable, super critical, CO | 11-21-2013 |
| 20140004205 | COMPOSITIONS AND METHODS USEFUL FOR AMELIORATING AGE RELATED MALADIES | 01-02-2014 |
| 20140023719 | PLANT DERIVED SEED EXTRACT RICH IN ESSENTIALLY FATTY ACIDS DERIVED FROM SALVIA HISPANICA L. SEED: COMPOSITION OF MATTER, MANUFACTURING PROCESS AND USE | 01-23-2014 |
| 20140056988 | Novel Inhibitors of Arachidonic Acid Formation - The invention relates to a novel class of inhibitors of arachidonic acid formation that can be useful for treating inflammatory conditions. Specifically, the invention relates to derivatives of sesamol that confer lower toxicity and increased circulatory lifetimes than pure sesamol. | 02-27-2014 |
| 20140072647 | USE OF VANADIUM COMPOUNDS FOR MAINTAINING NORMAGLYCEMIA IN A MAMMAL - The present invention relates to a method for maintaining normoglycemia in a mammal in need thereof, preferably a critically ill patient suffering from acute stress, and to a method for preventing or limiting renal ischemia-reperfusion (I/R) in a mammal, preferably in a critically ill patient suffering from acute stress. | 03-13-2014 |
| 20140134262 | METHOD OF TREATING ATHEROSCLEROSIS IN HIGH TRIGLYCERIDE SUBJECTS - The present invention provides a compound of Formula I: | 05-15-2014 |
| 20140154332 | FORMULAS COMPRISING HIGHLY SOLUBLE ELEMENTS AND VITAMIN FOR THE PREVENTION AND AMELIORATION OF OSTEOPOROSIS - The present invention provides methods of producing dosage forms for formulas of elemental compositions encompassing acetate salts of calcium, magnesium and zinc along with vitamin D | 06-05-2014 |
| 20140186454 | DHA AND EPA IN THE REDUCTION OF OXIDATIVE STRESS - The present invention generally relates to the prevention or treatment of disorders related to oxidative stress. For example, the present invention provides a composition for use in the prevention or treatment of oxidative stress related disorders under post-operative conditions. One embodiment of the present invention is a composition comprising DHA and EPA as active ingredients for use in the treatment or prevention of oxidative stress and/or related disorders. | 07-03-2014 |
| 20140205673 | PRODUCT FOR PARENTERAL NUTRITION OF OBESE INTENSIVE-CARE PATIENTS - The invention relates to a high-amino-acid, low-lipid and low-carbohydrate parenteral nutrition solution for administration to obese intensive-care patients, and to a three-chamber pouch which comprises the amino acid component, the carbohydrate component and the lipid component of the parenteral nutrition solution separately in three different chambers. | 07-24-2014 |
| 20140212505 | SPATIAL ARRANGEMENT OF PARTICLES IN A DRINKING DEVICE FOR ORAL DELIVERY OF PHARMACEUTICALS - The present invention relates to spatially arranging a plurality of particles in a device for the oral delivery of a pharmaceutical. In particular, the plurality of particles is utilized for the oral delivery of a pharmaceutical to a subject via the drinking device. | 07-31-2014 |
| 20140271908 | DIETARY SUPPLEMENTS AND METHODS FOR PREVENTING AND TREATING MIGRAINES - This document provides methods and materials related to preventing and treating migraines. For example, compositions (e.g., dietary supplements) containing one or more of coenzyme Q10, magnesium, riboflavin, pine bark extract, and fish oil are provided. | 09-18-2014 |
| 20140287054 | COMPOSITION COMPRISING BIOACTIVE AMINO ACIDS AND/OR PEPTIDES AND MARINE OIL IN A STABLE OIL-IN-WATER EMULSION, AND THE USE OF SAID COMPOSITION AS A FUNCTIONAL OR THERAPEUTIC COMPOSITION - The present invention relates to food supplements. Particularly, the present invention relates to a composition comprising marine oil in a stable oil-in-water emulsion, further comprising at least one specific bioactive amino acid or peptide, or derivatives thereof. In addition, the present invention relates to a process for the production of said composition and the use of said composition as a functional or therapeutic composition. | 09-25-2014 |
| 20140294987 | PLANT DERIVED SEED EXTRACT RICH IN ESSENTIAL FATTY ACIDS DERIVED FROM PERILLA SEED: COMPOSITION OF MATTER, MANUFACTURING PROCESS AND USE - A composition of matter comprises a shelf stable, super critical, CO | 10-02-2014 |
| 20140342009 | BOSWELLIA OIL, ITS FRACTIONS AND COMPOSITIONS FOR ENHANCING BRAIN FUNCTION - The present disclosure relates to non-acidic extracts or fractions selected from a | 11-20-2014 |
| 20150079191 | CURED GEL AND METHOD OF MAKING - A cured non-polymeric gel including a plurality of non-polymeric cross-links. The non-polymeric cross-links result from curing an oil or oil composition at selected curing conditions to achieve a desired amount of cross-linking to form the non-polymeric get. The desired amount of cross-linking is selected based on a desired rate of degradation of the gel after the gel is implanted. The oil or oil composition comprises one or more of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), or alphalinolenic acid (ALA). | 03-19-2015 |
| 20150140113 | GELLING AGENT-BASED DOSAGE FORM - The present invention generally relates to dosage forms for oral administration including one or more gelling agents. In particular, the present invention is directed to gelling agent-based dosage forms that are easily administered and taken, or swallowed. The present invention is also directed to gelling agent-based dosage forms that exhibit relatively low syneresis, are thermally stable, exhibit substantially constant active ingredient concentration, and/or exhibit one or more advantageous rheological properties. In particular, the present invention is directed to such gels containing one or more omega-3 fatty acids. The gelling agent-based dosage forms of the present invention are suitable for administration of a relatively large dose of active ingredient. The gelling agent-based dosage forms of the present invention are also suitable for administration of multiple active ingredients. Dosage forms of the present invention also provide tamper resistance and, thus, prevent recovery or diversion of active ingredients contained therein. The gelling agent-based dosage forms are also suitable for use as gastro-retentive and sustained release dosage forms. | 05-21-2015 |
| 20150313950 | USE OF CELLULAR EXTRACTS FOR SKIN REJUVENATION - The invention describes methods and agents for inducing in the skin one or more effects selected from stimulating fibroblast migration, stimulating elastin production, reducing expression of inflammatory factors and upregulating specific genes, thereby preventing skin cell aging processes and repairing skin damage. In preferred embodiments, the methods and agents comprise active extracts produced from fish eggs. | 11-05-2015 |
| 20150359824 | IMPROVED OMEGA-3 FOOD SUPPLEMENT BASED ON MARINE OIL - A food supplement omega 3 based on marine oils (extracted from fish, fish byproducts, mollusks, krill, algae, microalgae) to fight against hypercholesterolemia and lipoprotein disruption leading to atherosclerosis and so to cardiovascular diseases. Optimization of Lipid Prevention Score (LPS) of at least one food supplement omega 3 by adding either high or low LPS oil (vegetable and/or marine) according to the LPS of the omega 3 based marine oils. This action permits to make a well balanced fatty acid product that will have a better effect against the rising of bad cholesterol levels in the blood. This product can be prescribed as part of a preventive diet and/or curative treatment for cardiovascular diseases since such illnesses lead to the highest human mortality in the industrialized countries (about 180,000 deaths annually in France, which corresponds to 32% of total deaths). | 12-17-2015 |
| 20150376614 | MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS - Provided are methods, compounds, and compositions for reducing expression of ApoCIII mRNA and protein for treating, preventing, delaying, or ameliorating Fredrickson Type I dyslipidemia/FCS/LPLD, in a patient. Such methods, compounds, and compositions increase HDL levels and/or improving the ratio of TG to HDL and reducing plasma lipids and plasma glucose in the patient, and are useful to treat, prevent, delay, or ameliorate any one or more of pancreatitis, cardiovascular disease, metabolic disorder, and associated symptoms. | 12-31-2015 |
| 20160018422 | FATTY ACID PATTERN ANALYSIS FOR PREDICTING ACUTE CORANARY SYNDROME - The present invention provides blood based methods for predicting risk of acute coronary syndrome in a subject. | 01-21-2016 |
| 20160022754 | Supplement Composition and Methods of Use - The present disclosure provides a supplement composition for an animal comprising: cranberry oil in the volume range of 10-30%, 20-40% soybean oil in the volume range of and fish oil in the volume range of 30-70%. | 01-28-2016 |
| 20160038554 | Composition for reducing blood lipid and use thereof as healthcare dietary supplements - The present invention discloses a blood lipid-reducing composition, the active components of the composition are composed of fish oil, linseed oil, phytosterol ester or phytosterol. The composition mainly comprises components such as a-linolenic acid, EPA, DHA and phytosterol or phytosterol ester, can reduce serum total cholesterol (TC), triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C), has an efficacy of reducing blood lipid. The present invention also discloses the use of the blood lipid-reducing composition in the manufacture of health food having a function of reducing blood lipid. | 02-11-2016 |
| 20160081927 | PRE-SPRAY EMULSIONS AND POWDERS CONTAINING NON-POLAR COMPOUNDS - Provided are compositions and methods for producing water-soluble powders that contain additives such as essential fatty acids, including omega-3 fatty acids, omega-6 fatty acids, conjugated fatty acids, and other fatty acids; phytochemicals, including phytosterols; other oils; and coenzymes, including coenzyme Q10, and other oil-based additives. | 03-24-2016 |
| 20160082063 | COMPOSITION FOR PREVENTING OR TREATING STROKE OR DEGENERATIVE BRAIN DISEASE - The present invention relates to a composition for preventing and/or treating a stroke or a degenerative brain disease comprising: at least two substances selected from the group consisting of egg yolk lecithin, glycerol, sodium oleate, medium chain triglyceride and refined fish oil; olive oil; and soybean oil. The composition of the present invention has an excellent neuroprotective effect but no toxicity or side effects, and thus can be effectively and safely used for preventing, treating or ameliorating a stroke or a degenerative brain disease. | 03-24-2016 |
| 20160376519 | ENZYMATIC METHOD FOR SEPARATING PHYTANIC ACID FROM FATS OR OILS CONTAINING IT AND RECOVERING UNALTERED PRODUCTS FREE OF PHYTANIC ACID - Enzymatic method for separating phytanic acid from fats or oils containing it and recovering unaltered products free of phytanic acid | 12-29-2016 |
| 20220133741 | AAntihistamines In Combination With A Range Of Substances For Improved Health - The present invention provides for novel combinations comprising an antihistamine with selected pharmaceutical and nutraceutical agents which alleviate some of the symptoms experienced by menopausal women, optionally combined further with a range of indole-based natural products such as L-tryptophan, 5-hydroxytryptophan and melatonin. These mixtures may be enriched further with pharmaceutically acceptable calcium and magnesium salts as well as selected B vitamins. These combinations have utility in providing a medicament for improving health in mammals, especially for the improvement of menopausal symptoms as well as sleep in women. | 05-05-2022 |
